Market Research Logo

Almac Diagnostic Services Ltd - Product Pipeline Analysis, 2018 Update

Summary

Almac Diagnostic Services Ltd (Almac Diagnostic Services), a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer, and DDRD, is a predictive assay for immune-oncology and DNA damaging agent. Almac Diagnostic Services provides pre-clinical biomarker discovery to companion diagnostic development including regulatory submissions and commercialization. The company provides applications such as patient selection, and are utilised in phase I to phase III registrational clinical trials. It operates laboratories in the US and the UK. Almac Diagnostic Services is headquartered in Craigavon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Almac Diagnostic Services Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Almac Diagnostic Services Ltd Company Overview
    • Almac Diagnostic Services Ltd Company Snapshot
    • Almac Diagnostic Services Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Almac Diagnostic Services Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Almac Diagnostic Services Ltd Pipeline Products by Equipment Type
      • Table Figure 1: Almac Diagnostic Services Ltd Pipeline Products by Equipment Type
      • Table Almac Diagnostic Services Ltd Pipeline Products by Indication
  • Almac Diagnostic Services Ltd - Pipeline Analysis Overview
    • Almac Diagnostic Services Ltd - Key Facts
      • Table Almac Diagnostic Services Ltd, Key Facts
    • Almac Diagnostic Services Ltd - Major Products and Services
      • Table Almac Diagnostic Services Ltd, Major Products and Services
    • Almac Diagnostic Services Ltd Pipeline Products by Development Stage
      • Table Figure 2: Almac Diagnostic Services Ltd Pipeline Products by Development Stage
      • Table Almac Diagnostic Services Ltd Number of Pipeline Products by Development Stage
      • Table Almac Diagnostic Services Ltd Pipeline Products Summary by Development Stage
  • Almac Diagnostic Services Ltd Pipeline Products Overview
    • 2-Gene qPCR LDT
      • 2-Gene qPCR LDT Product Overview
        • Table 2-Gene qPCR LDT - Product Status
        • Table 2-Gene qPCR LDT - Product Description
    • ALM AADx Assay
      • ALM AADx Assay Product Overview
        • Table ALM AADx Assay - Product Status
        • Table ALM AADx Assay - Product Description
    • Angiogenesis Subtype Diagnostic Assay
      • Angiogenesis Subtype Diagnostic Assay Product Overview
        • Table Angiogenesis Subtype Diagnostic Assay - Product Status
        • Table Angiogenesis Subtype Diagnostic Assay - Product Description
    • Diagnostic Test - Ovarian Cancer
      • Diagnostic Test - Ovarian Cancer Product Overview
        • Table Diagnostic Test - Ovarian Cancer - Product Status
        • Table Diagnostic Test - Ovarian Cancer - Product Description
    • DNA Damage Response Deficiency Assay - Breast Cancer
      • DNA Damage Response Deficiency Assay - Breast Cancer Product Overview
        • Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
        • Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
    • DNA Damage Response Deficiency Assay - Colorectal Cancer
      • DNA Damage Response Deficiency Assay - Colorectal Cancer Product Overview
        • Table DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status
        • Table DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description
    • DNA Damage Response Deficiency Assay - Esophageal Cancer
      • DNA Damage Response Deficiency Assay - Esophageal Cancer Product Overview
        • Table DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Status
        • Table DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Description
    • DNA Damage Response Deficiency Assay - Ovarian Cancer
      • DNA Damage Response Deficiency Assay - Ovarian Cancer Product Overview
        • Table DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
        • Table DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
    • EMT Prognostic Assay
      • EMT Prognostic Assay Product Overview
        • Table EMT Prognostic Assay - Product Status
        • Table EMT Prognostic Assay - Product Description
    • NanoStrings's nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay
      • NanoStrings's nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay Product Overview
        • Table NanoStrings's nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Status
        • Table NanoStrings's nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Description
    • Next-Generation Sequencing Based Companion Diagnostic Assay
      • Next-Generation Sequencing Based Companion Diagnostic Assay Product Overview
        • Table Next-Generation Sequencing Based Companion Diagnostic Assay - Product Status
        • Table Next-Generation Sequencing Based Companion Diagnostic Assay - Product Description
    • Pan-Cancer Companion Diagnostic Assay
      • Pan-Cancer Companion Diagnostic Assay Product Overview
        • Table Pan-Cancer Companion Diagnostic Assay - Product Status
        • Table Pan-Cancer Companion Diagnostic Assay - Product Description
    • Predictive Assay - Immuno-oncology
      • Predictive Assay - Immuno-oncology Product Overview
        • Table Predictive Assay - Immuno-oncology - Product Status
        • Table Predictive Assay - Immuno-oncology - Product Description
    • Prognostic Test - Early Stage Lung Cancer
      • Prognostic Test - Early Stage Lung Cancer Product Overview
        • Table Prognostic Test - Early Stage Lung Cancer - Product Status
        • Table Prognostic Test - Early Stage Lung Cancer - Product Description
    • Prognostic Test - NSCLC
      • Prognostic Test - NSCLC Product Overview
        • Table Prognostic Test - NSCLC - Product Status
        • Table Prognostic Test - NSCLC - Product Description
    • Prostate Cancer Metastatic Assay
      • Prostate Cancer Metastatic Assay Product Overview
        • Table Prostate Cancer Metastatic Assay - Product Status
        • Table Prostate Cancer Metastatic Assay - Product Description
    • RSPO3 CLIA Assay
      • RSPO3 CLIA Assay Product Overview
        • Table RSPO3 CLIA Assay - Product Status
        • Table RSPO3 CLIA Assay - Product Description
  • Almac Diagnostic Services Ltd - Key Competitors
  • Almac Diagnostic Services Ltd - Key Employees
    • Table Almac Diagnostic Services Ltd, Key Employees
  • Almac Diagnostic Services Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Almac Diagnostic Services Ltd, Other Locations
  • Recent Developments
    • Almac Diagnostic Services Ltd, Recent Developments
      • Feb 12, 2018: DNAnexus Launches NGS Clinical Trial Solution
      • Oct 23, 2017: Queens University Belfast Leads Largest Study of its Kind to Transform Prostate Cancer Treatment
      • Jun 13, 2017: Almac Group Awarded U.S. Patents for Ground-breaking "DDRD" Assay
      • Apr 20, 2017: Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
      • Feb 16, 2017: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations
      • Jul 07, 2015: Almac Group Appoints Dr. John Robson as VP Quality Operations
      • Aug 14, 2014: Almac Group Announces 348 New Jobs in £54m Investment
      • Nov 30, 2011: Almac's Diagnostic Laboratory Receives Accreditation From College Of American Pathologists
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report